Literature DB >> 3610701

Combined modality treatment of adult soft tissue sarcomas of the head and neck.

W G McKenna, M M Barnes, T J Kinsella, S A Rosenberg, E E Lack, E Glatstein.   

Abstract

Between 1975 and 1985, 16 adult patients high grade soft tissue sarcomas arising in the head and neck were treated with combined modality therapy at the National Cancer Institute. Fifteen patients underwent an attempt at gross resection, while only a biopsy was performed in 1 patient. All patients received conventionally fractionated, high-dose, post-operative irradiation. Twelve of 16 patients received adjuvant chemotherapy with cyclophosphamide and adriamycin, given concomitantly with radiation therapy. With a median follow-up of 43 months from diagnosis (range 11-116 months), 10 patients (64%) are disease-free. Of these 10 patients, 1 presented with pulmonary metastases and 2 patients later failed in the lung; all pulmonary disease was resected and these patients are disease-free at 80, 115, and 116 months following presentation. Local control was maintained in 12 patients (75%). An analysis of the iso-effect lines for local control shows a slope of 0.32. The median NSD for local control was 1720 ret. We conclude that aggressive local management of high grade sarcomas which combines gross resection and high-dose post-operative irradiation results in excellent local control. The role of adjuvant chemotherapy is less well defined in this small patient series. The acute and late complications of this combined modality approach are manageable.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3610701     DOI: 10.1016/0360-3016(87)90184-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  [Soft tissue sarcoma of the head and neck area in adults. Outcome of combined surgery and irradiation and radiotherapy alone].

Authors:  H Willers; E B Hug; I J Spiro; J T Efird; A E Rosenberg; C C Wang
Journal:  Strahlenther Onkol       Date:  1997-03       Impact factor: 3.621

2.  Fibrosarcoma of the mandible: a diagnostic dilemma.

Authors:  Kanwar Deep Singh Nanda; Anurag Mehta; Jasmine Nanda
Journal:  J Clin Diagn Res       Date:  2013-08-01

3.  Angiosarcoma: A Case Report of Gingival Disease with Both Palatine Tonsils Localization.

Authors:  Frédéric Chamberland; Tristan Maurina; Séverine Degano-Valmary; Thierry Spicarolen; Loïc Chaigneau
Journal:  Rare Tumors       Date:  2016-10-05

4.  LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.

Authors:  Gang Qu; Zhiqiang Ma; Wenxian Tong; Jiahui Yang
Journal:  Mol Med Rep       Date:  2018-05-23       Impact factor: 2.952

5.  Tumor Suppressor WWOX inhibits osteosarcoma metastasis by modulating RUNX2 function.

Authors:  Sara Del Mare; Rami I Aqeilan
Journal:  Sci Rep       Date:  2015-08-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.